← Leaderboards
Robert T Tranquillo
University Of Minnesota Twin Cities
$20,629,815
Attributed
$21,207,386
Total exposure
10
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$21,207,386 · 10
By mechanism
R01$17,931,304 · 5
T32$1,155,142 · 1
R21$1,005,341 · 2
R61$747,254 · 1
R33$368,345 · 1
Top collaborators
- Victor H Barocas5 shared
Most similar at University Of Minnesota Twin Cities
Same institution · by research overlap
- Yuqing Huo$8,590,587
Others in their field
Top investigators on “Phenotype”
- David R. Weir · University Of Michigan At Ann Arbor$239,033,262
- David Heimbrook · Leidos Biomedical Research, Inc.$213,586,034
- Constance Ann Benson · University Of California, San Diego$187,132,366
- Richard A Gibbs · Baylor College Of Medicine$184,906,270
- James E. Gern · University Of Wisconsin-Madison$141,704,104
- Garret A Fitzgerald · University Of Pennsylvania$141,348,491
Research focus
PhenotypeTissue EngineeringTissuesFibrinEngineeringIn VitroCellsDesignImplantSuccessPerformancePositioning AttributeAdultGrowthTubeSheepImplantationMonitorFibroblastsHeart ValvesMechanicsPropertySurfaceBioreactors
Grant awards (40)
Biologically-engineered Transcatheter Vein Valve: Design Optimization and Preclinical Testing$368,345
R33 · FY2025 · HL · contact PI
Biologically-engineered Transcatheter Vein Valve: Design Optimization and Preclinical Testing$361,549
R61 · FY2024 · HL · contact PI
Biologically-engineered Transcatheter Vein Valve: Design Optimization and Preclinical Testing$385,705
R61 · FY2023 · HL · contact PI
Multidisciplinary training in cardiovascular engineering$235,184
T32 · FY2023 · HL · contact PI
Multidisciplinary training in cardiovascular engineering$278,773
T32 · FY2022 · HL · contact PI
Completely biological tissue-engineered pulmonic valve grown in vitro from human cells for pediatric patients$721,093
R01 · FY2021 · HL · contact PI
Multidisciplinary training in cardiovascular engineering$259,133
T32 · FY2021 · HL · contact PI
Completely biological tissue-engineered pulmonic valve grown in vitro from human cells for pediatric patients$732,181
R01 · FY2020 · HL · contact PI
Multidisciplinary training in cardiovascular engineering$255,790
T32 · FY2020 · HL · contact PI
Completely biological tissue-engineered pulmonic valve grown in vitro from human cells for pediatric patients$744,121
R01 · FY2019 · HL · contact PI
Multidisciplinary training in cardiovascular engineering$126,262
T32 · FY2019 · HL · contact PI
Completely biological tissue-engineered pulmonic valve grown in vitro from human cells for pediatric patients$706,356
R01 · FY2018 · HL · contact PI
Tissue-engineered pulmonic valve grown from human cells for pediatric patients$646,892
R01 · FY2015 · HL · contact PI
Biopolymer-guided human stem cell assembly for engineered myocardium$727,431
R01 · FY2014 · HL · contact PI
Tissue-engineered pulmonic valve grown from human cells for pediatric patients$694,222
R01 · FY2014 · HL · contact PI
Biopolymer-guided human stem cell assembly for engineered myocardium$707,655
R01 · FY2013 · HL · contact PI
Tissue-engineered pulmonic valve grown from human cells for pediatric patients$662,291
R01 · FY2013 · HL · contact PI
Biopolymer-guided human stem cell assembly for engineered myocardium$744,371
R01 · FY2012 · HL · contact PI
Tissue-engineered pulmonic valve grown from human cells for pediatric patients$656,744
R01 · FY2012 · HL · contact PI
Tissue-engineered pulmonic valve grown from human cells for pediatric patients$37,746
R01 · FY2012 · HL · contact PI
Perfusable and beating engineered myocardium from human progenitor cells based on$715,611
R01 · FY2011 · HL · contact PI
Completely biological tissue-engineered pulmonic valve grown in vitro from human$568,731
R01 · FY2011 · HL · contact PI
Systems biology approach to optimize tissue growth in vitro$174,462
R21 · FY2011 · EB · contact PI
Engineered Artery Growth in Vitro Based on Cell-Remodeled Fibrin$830,598
R01 · FY2010 · HL · contact PI
Systems biology approach to optimize tissue growth in vitro$209,309
R21 · FY2010 · EB · contact PI
Engineered Artery Growth in Vitro Based on Cell-Remodeled Fibrin$824,488
R01 · FY2009 · HL · contact PI
Engineered Artery Growth in Vitro Based on Cell-Remodeled Fibrin$963,730
R01 · FY2008 · HL · contact PI
Tissue-engineering Valve from Cell-Remodeled Biopolymer$852,363
R01 · FY2007 · HL · contact PI
Engineered Artery Growth in Vitro Based on Cell-Remodeled Fibrin$689,783
R01 · FY2007 · HL · contact PI
Tissue-engineering Valve from Cell-Remodeled Biopolymer$748,012
R01 · FY2006 · HL · contact PI
Engineered Artery Growth in Vitro, Cell-Remodeled Fibrin$554,869
R01 · FY2006 · HL · contact PI
Tissue-engineering Valve from Cell-Remodeled Biopolymer$752,949
R01 · FY2005 · HL
Tissue-engineering Valve from Cell-Remodeled Biopolymer$743,806
R01 · FY2004 · HL
Biopolymer-Mimetic Worm-like Micelle Tissue Scaffolds$207,027
R21 · FY2004 · EB
Tissue-engineering Valve from Cell-Remodeled Biopolymer$1,017,459
R01 · FY2003 · HL
Biopolymer-Mimetic Worm-like Micelle Tissue Scaffolds$207,192
R21 · FY2003 · EB
DEVELOPMENT OF A BIOARTIFICIAL ARTERY$298,397
R01 · FY2002 · HL
Biopolymer-Mimetic Worm-like Micelle Tissue Scaffolds$207,351
R21 · FY2002 · EB
DEVELOPMENT OF A BIOARTIFICIAL ARTERY$294,157
R01 · FY2001 · HL
DEVELOPMENT OF A BIOARTIFICIAL ARTERY$295,248
R01 · FY2000 · HL